(MedPage Today) -- Publication of landmark trial results affirmed no benefit and worrisome adverse events from adding extended-release niacin to statin therapy, but many physicians weren't ready to concede failure of the purported HDL mechanism. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment